Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Gross Profit (2021 - 2023)

Historic Gross Profit for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $763000.0.

  • ADC Therapeutics' Gross Profit fell 9898.3% to $763000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $69.3 billion, marking a year-over-year increase of 5086656.01%. This contributed to the annual value of -$4.6 billion for FY2022, which is 1580731.57% down from last year.
  • ADC Therapeutics' Gross Profit amounted to $763000.0 in Q3 2023, which was down 9898.3% from $4.8 million recorded in Q2 2023.
  • ADC Therapeutics' Gross Profit's 5-year high stood at $69.3 billion during Q4 2022, with a 5-year trough of -$13.9 million in Q1 2021.
  • For the 3-year period, ADC Therapeutics' Gross Profit averaged around $6.3 billion, with its median value being $12.6 million (2021).
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 42677945665.02% in 2022, then crashed by 9898.3% in 2023.
  • Quarter analysis of 3 years shows ADC Therapeutics' Gross Profit stood at $16240.0 in 2021, then soared by 426779456.65% to $69.3 billion in 2022, then tumbled by 100.0% to $763000.0 in 2023.
  • Its last three reported values are $763000.0 in Q3 2023, $4.8 million for Q2 2023, and $18.4 million during Q1 2023.